SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 95 400 KRW -2.25% Market Closed
Market Cap: 7.5T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
SK Biopharmaceuticals Co Ltd

Wall Street analysts forecast SK Biopharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Biopharmaceuticals Co Ltd is 124 518.46 KRW with a low forecast of 57 570 KRW and a high forecast of 157 500 KRW.

Lowest
Price Target
57 570 KRW
40% Downside
Average
Price Target
124 518.46 KRW
31% Upside
Highest
Price Target
157 500 KRW
65% Upside
SK Biopharmaceuticals Co Ltd Competitors:
Price Targets
600867
Tonghua Dongbao Pharmaceutical Co Ltd
35% Upside
1666
Tong Ren Tang Technologies Co Ltd
31% Upside
300363
Porton Pharma Solutions Ltd
57% Upside
PER
Percheron Therapeutics Ltd
194% Upside
1477
Ocumension Therapeutics
95% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
35% Upside
ORCHPHARMA
Orchid Pharma Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
SK Biopharmaceuticals Co Ltd

For the last 5 years the compound annual growth rate for SK Biopharmaceuticals Co Ltd's revenue is 218%. The projected CAGR for the next 3 years is 33%.

218%
Past Growth
33%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
SK Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
SK Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SK Biopharmaceuticals Co Ltd's stock price target?
Price Target
124 518.46 KRW

According to Wall Street analysts, the average 1-year price target for SK Biopharmaceuticals Co Ltd is 124 518.46 KRW with a low forecast of 57 570 KRW and a high forecast of 157 500 KRW.

What is SK Biopharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 5 years the compound annual growth rate for SK Biopharmaceuticals Co Ltd's revenue is 218%. The projected CAGR for the next 3 years is 33%.

Back to Top